<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">78163</article-id><article-id pub-id-type="doi">10.7554/eLife.78163</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>Human WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-272384"><name><surname>Cai</surname><given-names>Wesley L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272383"><name><surname>Chen</surname><given-names>Jocelyn Fang-Yi</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7281-8686</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272385"><name><surname>Chen</surname><given-names>Huacui</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272386"><name><surname>Wingrove</surname><given-names>Emily</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272387"><name><surname>Kurley</surname><given-names>Sarah J</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273188"><name><surname>Chan</surname><given-names>Lok Hei</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273189"><name><surname>Zhang</surname><given-names>Meiling</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273190"><name><surname>Arnal-Estape</surname><given-names>Anna</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0490-7040</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273191"><name><surname>Zhao</surname><given-names>Minghui</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273192"><name><surname>Balabaki</surname><given-names>Amer</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1509-886X</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-209844"><name><surname>Li</surname><given-names>Wenxue</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273193"><name><surname>Yu</surname><given-names>Xufen</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7794-7890</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-288320"><name><surname>Krop</surname><given-names>Ethan D</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217941"><name><surname>Dou</surname><given-names>Yali</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-209843"><name><surname>Liu</surname><given-names>Yansheng</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2626-3912</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-130905"><name><surname>Jin</surname><given-names>Jian</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2387-3862</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-3015"><name><surname>Westbrook</surname><given-names>Thomas F</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-6306"><name><surname>Nguyen</surname><given-names>Don X</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" corresp="yes" id="author-38365"><name><surname>Yan</surname><given-names>Qin</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4077-453X</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Hillman Cancer Center</institution>, <institution>University of Pittsburgh Medical Center</institution>, <addr-line><named-content content-type="city">Pittsburgh</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Pathology</institution>, <institution>Yale University</institution>, <addr-line><named-content content-type="city">New Haven</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Biochemistry and Molecular Biology</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Pharmacology</institution>, <institution>Yale University</institution>, <addr-line><named-content content-type="city">West Haven</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Mount Sinai Center for Therapeutics Discovery</institution>, <institution>Icahn School of Medicine at Mount Sinai</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Department of Medicine</institution>, <institution>University of Southern California</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Department of Pharmacological Sciences</institution>, <institution>Icahn School of Medicine at Mount Sinai</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><institution content-type="dept">Department of Molecular and Human Genetics</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-31092"><name><surname>Zwart</surname><given-names>Wilbert</given-names></name><role>Reviewing editor</role><aff><institution>Netherlands Cancer Institute</institution>, <country>Netherlands</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>don.nguyen@yale.edu</email> (DN);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>qin.yan@yale.edu</email> (QY);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>31</day><month>08</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e78163</elocation-id><history><date date-type="received"><day>25</day><month>02</month><year>2022</year></date><date date-type="accepted"><day>24</day><month>08</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Cai et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Cai et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-78163-v1.pdf"/><abstract><p>Metastatic breast cancer remains a major cause of cancer related deaths in women and there are few effective therapies against this advanced disease. Emerging evidence suggests that key steps of tumor progression and metastasis are controlled by reversible epigenetic mechanisms. Using an <italic>in vivo</italic> genetic screen, we identified WDR5 as an actionable epigenetic regulator that is required for metastatic progression in models of triple-negative breast cancer. We found that knockdown of WDR5 in breast cancer cells independently impaired their tumorigenic as well as metastatic capabilities. Mechanistically, WDR5 promotes cell growth by increasing ribosomal gene expression and translation efficiency in a KMT2-independent manner. Consistently, pharmacological inhibition or degradation of WDR5 impedes cellular translation rate and the clonogenic ability of breast cancer cells. Furthermore, combination of WDR5-targeting with mTOR inhibitors leads to potent suppression of translation and proliferation of breast cancer cells. These results reveal novel therapeutic strategies to treat metastatic breast cancer.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>Graduate Research FellowshipDGE-1122492</award-id><principal-award-recipient><name><surname>Cai</surname><given-names>Wesley L</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>F31CA243295</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Jocelyn Fang-Yi</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000090</institution-id><institution>Congressionally Directed Medical Research Programs</institution></institution-wrap></funding-source><award-id>W81XWH-15-1-0117 and W81XWH-21-1-0411</award-id><principal-award-recipient><name><surname>Yan</surname><given-names>Qin</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>R01CA237586</award-id><principal-award-recipient><name><surname>Yan</surname><given-names>Qin</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>R01CA166376</award-id><principal-award-recipient><name><surname>Nguyen</surname><given-names>Don X</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>P30CA016359</award-id><principal-award-recipient><name><surname>Yan</surname><given-names>Qin</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010900</institution-id><institution>Yale Cancer Center</institution></institution-wrap></funding-source><award-id>Class of '61 Cancer Research Award</award-id><principal-award-recipient><name><surname>Yan</surname><given-names>Qin</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010900</institution-id><institution>Yale Cancer Center</institution></institution-wrap></funding-source><award-id>Class of '61 Cancer Research Award</award-id><principal-award-recipient><name><surname>Nguyen</surname><given-names>Don X</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Jian Jin, . The Jin laboratory received research funds un-related to this study from Celgene Corporation, Levo Therapeutics, Inc., Cullgen, Inc. and Cullinan Oncology, Inc. J.J. is a cofounder, scientific advisory board member and equity shareholder in Cullgen, Inc. and a consultant for Cullgen, Inc., EpiCypher, Inc. and Accent Therapeutics, Inc..</p></fn><fn fn-type="conflict" id="conf3"><p>Don X Nguyen, has received research funding un-related to this study from AstraZeneca Inc..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal procedures have been approved by the Institutional Animal Care and Use Committee of Yale University under animal protocol 2021-11286.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>RNA-seq data have been deposited into the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus database under GSE196666. Reviewer token: qhqpeackxnebvqn.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Cai WL</collab><collab>Chen JF</collab><collab>Yan Q</collab></person-group><year iso-8601-date="2022">2022</year><source>WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE196666">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE196666</ext-link><comment>NCBI Gene Expression Omnibus, GSE196666</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-78163-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>